Understanding and addressing the risks of using opioids and benzodiazepines together
Opioid/benzodiazepine polydrug abuse: Integrating research on mechanisms, treatment and policies
This study is looking at how using both opioids and benzodiazepines together can increase the risk of overdose and other health problems, and it's for anyone who is dealing with these substances to help find better ways to support their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10685979 on NIH RePORTER |
What this research studies
This research investigates the complex issue of polydrug abuse involving opioids and benzodiazepines, focusing on the risks of overdose and disability. It aims to identify specific patient characteristics that contribute to these risks by analyzing data from behavioral health treatment records and conducting in-depth clinical assessments. The study employs a combination of population-level analysis and clinical evaluations to understand how these substances affect mental health and physical well-being. By integrating various methodologies, the research seeks to develop targeted interventions for those affected by this dual substance use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are currently using both opioids and benzodiazepines and are experiencing related health issues.
Not a fit: Patients who are not using either opioids or benzodiazepines or those who do not have any associated health complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that reduce the risks associated with polydrug abuse, ultimately saving lives and enhancing patient well-being.
How similar studies have performed: Previous research has shown that addressing polydrug abuse through targeted interventions can lead to significant improvements in patient outcomes, suggesting that this approach has potential for success.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Greenwald, Mark K — Wayne State University
- Study coordinator: Greenwald, Mark K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.